
Gleason grading system Information | Mount Sinai - New York
May 30, 2024 · Learn about Gleason grading system or find a doctor at Mount Sinai Health System.
Prostate cancer Information | Mount Sinai - New York
Learn about Prostate cancer, find a doctor, complications, outcomes, recovery and follow-up care for Prostate cancer.
Prostate biopsy Information | Mount Sinai - New York
Learn about Prostate biopsy, find a doctor, complications, outcomes, recovery and follow-up care for Prostate biopsy.
Prostate cancer staging Information | Mount Sinai - New York
The higher the stage, the more advanced the cancer. Stage I cancer. The cancer is found only in one part of the prostate. Stage I is called localized prostate cancer. It cannot be felt during a …
High Intensity Focused Ultrasound (HIFU) - Mount Sinai Health …
High-Intensity Focused Ultrasound or HIFU is a non-invasive heating procedure for treating localized prostate cancer.
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate …
Jan 16, 2024 · Summary: This is a partially blinded randomized controlled phase II pilot study comparing Poly-ICLC (Hiltonol®) treatment vs no treatment, for prostate cancer participants …
If you have cancer that is clinically insignifi cant (Gleason 6), we would recommend active surveillance. However, if there is clinically signifi cant cancer (any Gleason 7, more than 2 …
Turning 18 Months into 18 Years | Mount Sinai - New York
When Bill was first informed of his advanced disease (Gleason Total Score 9, Grade T-3A) in 1995, the recommendation to go on hormone therapy with Lupron. In addition, Bill made …
Active Surveillance | Mount Sinai - New York
Gleason score of 6 or less, prostate-specific antigen (PSA) less than 10 mg/ml Tumor that cannot be felt or can be felt in less than half of one lobe of the prostate Classified as clinical stage T1c …
Pathology Test Uses Artificial Intelligence to Predict Prostate …
Oct 2, 2018 · A pathology test that applies artificial intelligence (AI) to characterize tissue samples can accurately predict clinically significant prostate cancer disease progression following …